A phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 5, 2011, Pages 1306-1315

  Lock, Michael ^a   Best, Lara ^a   Wong, Eugene ^a   Bauman, Glenn ^a   D'Souza, David ^a   Venkatesan, Varagur ^a   Sexton, Tracy ^a   Ahmad, Belal ^a   Izawa, Jonathan ^b   Rodrigues, George ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Arc based radiotherapy; Clinical trial; Hypofractionation; Phase II; Prostate cancer

Indexed keywords

ARC-BASED RADIOTHERAPY; CLINICAL TRIAL; HYPOFRACTIONATION; PHASE II; PROSTATE CANCERS;

DISEASES; EXPERIMENTS; PHYSICAL THERAPY; RADIOTHERAPY; ULTRASONICS;

TOXICITY;

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ANTICOAGULATION; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLOSTRIDIUM DIFFICILE INFECTION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; CYSTITIS; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FECES INCONTINENCE; FIDUCIAL MARKER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL PAIN; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEMATURIA; HEMICOLECTOMY; HUMAN; HYPOFRACTIONATED INTENSITY MODULATED RADIATION THERAPY; INTENSITY MODULATED RADIATION THERAPY; INTESTINE PERFORATION; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; SMALL INTESTINE OBSTRUCTION; ULTRASOUND; URINE INCONTINENCE; UROGENITAL TRACT DISEASE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANAL CANAL; DIARRHEA; DOSE FRACTIONATION; FIDUCIAL MARKERS; FOLLOW-UP STUDIES; GOLD; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; SEMINAL VESICLES; TUMOR BURDEN; ULTRASONOGRAPHY, INTERVENTIONAL; URINARY BLADDER; URINATION DISORDERS;

EID: 79960102464     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.04.054     Document Type: Article

References (48)

1. L. Marrett, D. Dryer, and L. Ellison Canadian cancer statistics 2008 2008 National Cancer Institute of Canada Toronto 1-85
2. A. Pollack, L. Smith, and A. von Eschenback External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era Int J Radiat Oncol Biol Phys 48 2000 507 512
3. A. Pollack, and G. Zagars External beam radiotherapy dose response of prostate cancer Int J Radiat Oncol Biol Phys 39 1997 111 118
4. J. Mui, C. Catton, and P. Ward Radical irradiation of localized prostate cancer: Prognosis and outcome based on clinical and biochemical assessment Int J Radiat Oncol Biol Phys 1998 46S
5. A. Zietman, J. Coen, and K.C. Dallow The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcome Int J Radiat Oncol Biol Phys 32 1995 287 292
6. M.K. Martel, R.K. Ten Haken, and M.B. Hazuka Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1999 31 37 (Pubitemid 29241815)
7. G.E. Hanks, A.L. Hanlon, and T.E. Schyultheiss Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions Int J Radiat Oncol Biol Phys 41 1998 501 510 (Pubitemid 28275077)
8. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239 (Pubitemid 41352111)
9. S.T.H. Peeters, W.D. Heemsbergen, and P.C.M. Koper Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996 (Pubitemid 46622106)
10. V. Fonteyne, G. Villeirs, and B. Speleers Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion Int J Radiat Oncol Biol Phys 72 2008 799 807
11. E. Wong, J. Chen, and J. Greenland Intensity modulated arc therapy simplified Int J Radiat Oncol Biol Phys 53 2001 222 235
12. G.E. Hanks, A.L. Hanlon, and B. Epstein Dose response in prostate cancer with 8-12 years' follow-up Int J Radiat Oncol Biol Phys 54 2002 427 435 (Pubitemid 35286808)
13. P.A. Kupelian, D.S. Mohan, and J. Lyons Higher than standard radiation doses (> or = 72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer Int J Radiat Oncol Biol Phys 46 2000 567 574 (Pubitemid 30100633)
14. M. Zelefsky, S. Leibel, and P. Gaudin Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 41 1998 491 500 (Pubitemid 28275076)
15. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105 (Pubitemid 34787842)
16. J.J. Coen, A.L. Zietman, and H. Thakral Radical radiation for localized prostate cancer: Local persistence of disease results in a late wave of metastases J Clin Oncol 20 2002 3199 3205 (Pubitemid 34831515)
17. R. Jacob, A.L. Hanlon, and E.M. Horwitz The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer Cancer 100 2004 538 543 (Pubitemid 38124771)
18. A.P. Legorreta, R.H. Brooks, and A.N. Leibowitz Cost of breast cancer treatment: A 4-year longitudinal study Arch Intern Med 156 1996 2197 2201 (Pubitemid 26361912)
19. J.M. Martin, T. Rosewall, and A. Bayley Phase II trial of hypofractionated image-guided intensity modulated radiotherapy for localized prostate adenocarcinoma Int J Radiat Oncol Biol Phys 69 2007 1084 1089 (Pubitemid 47625844)
20. J. Livsey, R.A. Cowan, and J.P. Wylie Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis Int J Radiat Oncol Biol Phys 57 2003 1254 1259 (Pubitemid 37443962)
21. A. Pollack, A.L. Hanlon, and E.M. Horwitz Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial Int J Radiat Oncol Biol Phys 64 2006 518 526 (Pubitemid 43083441)
22. M.A. Ritter, R.J. Chappell, and J.F. Fowler A multi-institutional phase I/II trial of hypofractionated radiation therapy for localized prostate cancer [Abstract] D. Buckley, 2005 Multidisciplinary Prostate Cancer Symposium/Proceedings 2005 American Society of Clinical Oncology Alexandria VA 79
23. D.J. Brenner, and E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1111
24. A. Dasu Is the α/β value for prostate tumors low enough to be safely used in clinical trials? Clin Oncol 19 2007 289 301 (Pubitemid 46760594)
25. S.M. Bentzen, and M.A. Ritter The α/β ratio for prostate cancer: What is it, really? [editorial] Radiother Oncol 76 2005 1 3 (Pubitemid 41096507)
26. S.G. Williams, J.M.G. Taylor, and H. Liu Use of individual fraction size data from 3756 patients to directly determine the α/β ratio of prostate cancer Int J Radiat Oncol Biol Phys 68 2007 23 33
27. E.E. Yeoh, R.J. Fraser, and R.E. McGowan Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: Early results of a Phase III randomized trial Int J Radiat Oncol Biol Phys 55 2003 943 955 (Pubitemid 36286996)
28. E.E. Yeoh, R.H. Holloway, and R.J. Fraser Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial Int J Radiat Oncol Biol Phys 66 2006 1072 1083 (Pubitemid 44633501)
29. H. Lukka, C. Hayter, and J.A. Julian Randomized trial comparing two fractionation schedules for patients with localized prostate cancer J Clin Oncol 23 2005 6132 6138
30. D. Palma, E. Vollans, and K. James Volumetric modulated arc therapy for delivery of prostate cancer radiotherapy: Comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 72 2008 996 1001
31. T.R. Mackie, J. Balog, and K. Ruchala Tomotherapy. Semin Radiat Oncol 9 1999 108 117
32. C.X. Yu Intensity-modulated arc therapy with dynamic multileaf collimation: An alternative to tomotherapy Phys Med Biol 40 1995 1435 1449
33. G. Bauman, E. Gete, and J.Z. Chen Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy Med Dosim 29 2004 18 25 (Pubitemid 38352828)
34. G. Bauman, E. Wong, and E. Gete A comparison of class solutions using arc and fixed beam intensity modulated radiotherapy for prostate cancer treatment Radiother Oncol 69 1 Suppl 2003 S6
35. M. Roach III The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 1923 1993
36. NCI Common Terminology Criteria for Adverse Events v3.0. 2006 http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3. pdf. Last accessed July 1, 2010.
37. M. Roach III, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference Int J Radiat Oncol Biol Phys 65 2006 965 974
38. M. Lock, E. Wong, and G. Rodrigues Hypofractionated prostate arc radiotherapy using ultrasound localization Radiother Oncol 80 Suppl 1 2006 S10
39. P. Cheung, K. Sixel, and G. Morton Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer Int J Radiat Oncol Biol Phys 62 2005 418 425 (Pubitemid 40704458)
40. P.A. Kupelian, V.V. Thakkar, and D. Khuntia Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long term outcomes Int J Radiat Oncol Biol Phys 63 2005 1463 1468 (Pubitemid 41628043)
41. P.A. Kupelian, T.R. Willoughby, and C. Reddy Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430 (Pubitemid 47176809)
42. G. Soete, S. Arcangeli, and G. De Meerleer Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity Radiother Oncol 80 2006 78 81 (Pubitemid 44205307)
43. T.S. Lim, P.C.F. Cheung, and A. Loblaw Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results Int J Radiat Oncol Biol Phys 72 2008 85 92
44. S. Arcangeli, L. Strigari, and G. Soete Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: Results from a multicentric prospective trial Int J Radiat Oncol Biol Phys 73 2009 39 45
45. J.H. Coote, J.P. Wylie, and R.A. Cowan Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: Analysis of toxicity Int J Radiat Oncol Biol Phys 74 2009 1121 1127
46. R. McCammon, K.E. Rusthoven, and B. Kavanagh Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer Int J Radiat Oncol Biol Phys 75 2009 413 420
47. N. Pervez, C. Small, and M. MacKenzie Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 76 2010 57 64
48. J. Fowler, and C.R. King Don't squeeze hypofractionated schedules into too-short overall times Int J Radiat Oncol Biol Phys 75 2009 323 325